Filing Details

Accession Number:
0001209191-20-036749
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2020-06-15 18:39:11
Reporting Period:
2020-06-15
Accepted Time:
2020-06-15 18:39:11
Original Submission Date:
2020-06-15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1427925 Acelrx Pharmaceuticals Inc ACRX () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1248144 Adrian Adams C/o Acelrx Pharmaceuticals, Inc.
351 Galveston Drive
Redwood City CA 94063
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-15 100,000 $1.29 178,750 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $1.27 to $1.30 on June 15, 2020. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price.